252 related articles for article (PubMed ID: 12932244)
1. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis.
Hoefnagel JJ; Thio HB; Willemze R; Bouwes Bavinck JN
Br J Dermatol; 2003 Aug; 149(2):363-9. PubMed ID: 12932244
[TBL] [Abstract][Full Text] [Related]
2. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.
Mrowietz U; Christophers E; Altmeyer P
Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799
[TBL] [Abstract][Full Text] [Related]
3. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.
Harries MJ; Chalmers RJ; Griffiths CE
Br J Dermatol; 2005 Sep; 153(3):549-51. PubMed ID: 16120141
[TBL] [Abstract][Full Text] [Related]
4. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
Balasubramaniam P; Stevenson O; Berth-Jones J
Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
[TBL] [Abstract][Full Text] [Related]
5. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study.
Dickel H; Bruckner T; Altmeyer P
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996
[TBL] [Abstract][Full Text] [Related]
6. Fumaric acid ester-induced T-cell lymphopenia in the real-life treatment of psoriasis.
Dickel H; Bruckner T; Höxtermann S; Dickel B; Trinder E; Altmeyer P
J Eur Acad Dermatol Venereol; 2019 May; 33(5):893-905. PubMed ID: 30680823
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria with fumaric acid ester treatment for psoriasis.
Ogilvie S; Lewis Jones S; Dawe R; Foerster J
Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
[TBL] [Abstract][Full Text] [Related]
9. Renal dysfunction in patients taking fumaric acid esters - a retrospective cross-sectional study.
Menzies S; Ismail N; Abdalla A; Collins P; Kirby B; Holian J; Lally A
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):686-691. PubMed ID: 27790753
[TBL] [Abstract][Full Text] [Related]
10. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study.
Tzaneva S; Geroldinger A; Trattner H; Tanew A
Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862
[TBL] [Abstract][Full Text] [Related]
11. Fumaric acid esters for psoriasis: a systematic review.
Smith D
Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164
[TBL] [Abstract][Full Text] [Related]
12. Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial.
Balak DM; Fallah-Arani S; Venema CM; Neumann HA; Thio HB
Br J Dermatol; 2015 Mar; 172(3):754-9. PubMed ID: 25041291
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands.
Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB
Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641
[TBL] [Abstract][Full Text] [Related]
14. Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care.
Mrowietz U; Sorbe C; Reich K; Von Kiedrowski R; Weckbecker J; Radtke MA; Rustenbach SJ; Augustin M
Eur J Dermatol; 2020 Feb; 30(1):41-48. PubMed ID: 32250255
[TBL] [Abstract][Full Text] [Related]
15. Fumaric acid esters in the management of psoriasis.
Balak DM
Psoriasis (Auckl); 2015; 5():9-23. PubMed ID: 29387578
[TBL] [Abstract][Full Text] [Related]
16. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference.
Mrowietz U; Christophers E; Altmeyer P
Br J Dermatol; 1999 Sep; 141(3):424-9. PubMed ID: 10584060
[TBL] [Abstract][Full Text] [Related]
17. Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters.
Sondermann W; Rompoti N; Leister L; Huptas L; Klode J; Dissemond J; Körber A
Dermatology; 2017; 233(4):295-302. PubMed ID: 28954274
[TBL] [Abstract][Full Text] [Related]
18. Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris.
Gollnick H; Altmeyer P; Kaufmann R; Ring J; Christophers E; Pavel S; Ziegler J
Dermatology; 2002; 205(1):46-53. PubMed ID: 12145434
[TBL] [Abstract][Full Text] [Related]
19. Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study.
Schmieder A; Poppe M; Hametner C; Meyer-Schraml H; Schaarschmidt ML; Findeisen P; Benoit S; Bauer B; Schmid S; Goebeler M; Goerdt S; Ludwig-Peitsch WK
Arch Dermatol Res; 2015 Jul; 307(5):413-24. PubMed ID: 25648959
[TBL] [Abstract][Full Text] [Related]
20. Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients.
Balak DMW; Hajdarbegovic E; Bramer WM; Neumann HAM; Thio HB
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1475-1482. PubMed ID: 28322482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
